Skip to main
ATR
ATR logo

Aptargroup (ATR) Stock Forecast & Price Target

Aptargroup (ATR) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AptarGroup exhibits strong growth potential, particularly within its AMS Solutions segment, which has achieved a compound annual growth rate (CAGR) of approximately 10%, accounting for about 11% of Pharma’s revenue and 5% of total revenue for FY24. The company's Injectables business is experiencing significant growth as well, with a CAGR of 9%, driven by the shift towards biologics and rising demand for GLP-1 medications. This dual growth in specialized segments is expected to contribute to margin expansion, positioning AptarGroup favorably for sustained financial performance.

Bears say

AptarGroup faces a prolonged transition to a majority Pharma focus, which may delay anticipated growth and margin expansion, contributing to a negative outlook. The company operates globally, exposing it to currency fluctuations and economic cycles that can adversely affect demand across its key markets. Additionally, regulatory risks, supply chain vulnerabilities, and the potential loss of competitive advantages due to intellectual property issues further exacerbate concerns regarding the company's financial position.

Aptargroup (ATR) has been analyzed by 4 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aptargroup and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aptargroup (ATR) Forecast

Analysts have given Aptargroup (ATR) a Buy based on their latest research and market trends.

According to 4 analysts, Aptargroup (ATR) has a Buy consensus rating as of Dec 18, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $167.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $167.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aptargroup (ATR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.